These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17882957)

  • 41. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
    Fattori D; Rossi C; Fincham CI; Berettoni M; Calvani F; Catrambone F; Felicetti P; Gensini M; Terracciano R; Altamura M; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
    J Med Chem; 2006 Jun; 49(12):3602-13. PubMed ID: 16759102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and biological evaluation of novel 7-mercaptocoumarin derivatives as α(1)-adrenoceptor antagonists.
    Xie SS; Wang XB; Li JY; Kong LY
    Chem Pharm Bull (Tokyo); 2013; 61(1):16-24. PubMed ID: 23302583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and activity of newly designed aroxyalkyl or aroxyethoxyethyl derivatives of piperazine on the cardiovascular and the central nervous systems.
    Waszkielewicz AM; Kubacka M; Pańczyk K; Mogilski S; Siwek A; Głuch-Lutwin M; Gryboś A; Filipek B
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5315-5321. PubMed ID: 27692547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
    Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and synthesis of selective alpha1B adrenoceptor antagonists.
    Hayashi R; Ohmori E; Isogaya M; Moriwaki M; Kumagai H
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4045-7. PubMed ID: 16723224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative structure-activity relationship analysis of aryl alkanol piperazine derivatives with antidepressant activities.
    Chen KX; Li ZG; Xie HY; Gao JR; Zou JW
    Eur J Med Chem; 2009 Nov; 44(11):4367-75. PubMed ID: 19581024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of a series of piperazine-1-carboxamidine derivatives with antifungal activity resulting from accumulation of endogenous reactive oxygen species.
    François IE; Thevissen K; Pellens K; Meert EM; Heeres J; Freyne E; Coesemans E; Viellevoye M; Deroose F; Martinez Gonzalez S; Pastor J; Corens D; Meerpoel L; Borgers M; Ausma J; Dispersyn GD; Cammue BP
    ChemMedChem; 2009 Oct; 4(10):1714-21. PubMed ID: 19705386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
    Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
    Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and alpha(1)-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion.
    Betti L; Floridi M; Giannaccini G; Manetti F; Paparelli C; Strappaghetti G; Botta M
    Bioorg Med Chem; 2004 Mar; 12(6):1527-35. PubMed ID: 15018926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel piperazines: potent melanocortin-4 receptor antagonists with anxiolytic-like activity.
    Nozawa D; Okubo T; Ishii T; Takamori K; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2007 Mar; 15(6):2375-85. PubMed ID: 17267226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
    Marona H; Szkaradek N; Rapacz A; Filipek B; Dybała M; Siwek A; Cegła M; Szneler E
    Bioorg Med Chem; 2009 Feb; 17(3):1345-52. PubMed ID: 19131251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors.
    Maciag D; Filipek B; Czekaj T; Marona H; Nowak G
    Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.
    Handzlik J; Bajda M; Zygmunt M; Maciąg D; Dybała M; Bednarski M; Filipek B; Malawska B; Kieć-Kononowicz K
    Bioorg Med Chem; 2012 Apr; 20(7):2290-303. PubMed ID: 22381672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
    Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
    Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.
    Jin J; Wang XB; Kong LY
    Bioorg Med Chem Lett; 2011 Feb; 21(3):909-11. PubMed ID: 21236664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
    Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Synthetic studies on antihypertensive agents. Synthesis and pharmacological study of substituted-hydralazine-like compounds (author's transl)].
    Eguchi Y; Nakajima M; Kaneko S; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1978; 12():41-51. PubMed ID: 296817
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis and pharmacological evaluation of new arylpiperazines N-[4-[4-(aryl) piperazine-1-yl]-phenyl]-amine derivatives: putative role of 5-HT1A receptors.
    Khatri M; Rai SK; Alam S; Vij A; Tiwari M
    Bioorg Med Chem; 2009 Mar; 17(5):1890-7. PubMed ID: 19223188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
    Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
    J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.